Look Towards A New Future

Mar 9, 2012

Global Markets for Telemedicine Technologies

The global telemedicine market is expected to grow from $9.8 billion in 2010 to $11.6 billion in 2011, and to $27.3 billion in 2016, a compound annual growth rate (CAGR) of 18.6% over the next five years.
The telehospital/clinic market segment was worth $8.1 billion in 2011. This is expected to grow to $17.6 billion in 2016, demonstrating a CAGR of 16.8% between 2011 and 2016.
The telehome segment is growing faster than the telehospital/clinic segment. This market segment was valued at $3.5 billion in 2011, and this revenue is expected to grow at a CAGR of 22.5%, reaching $9.7 billion in 2016

This report is intended for telemedicine hardware manufacturers, software providers, telecom and networking companies, the healthcare industry and healthcare insurance companies. Key takeaways include the identification and quantification of markets for technology and services in the telemedicine market. Opportunities are defined in terms of market forecasts, avenues, trends, market drivers and competitive gaps.

This includes hardware manufacturers of home care units (e.g., vital signals), videoconferencing equipment and store-and-forward (i.e., radiological and pathological) units. The report provides market forecasts for the five-year period from 2011 through 2016. It provides analysis of recent technology developments and includes profiles of main players, benchmarking information, key buying criteria and value-chain mapping.

Market forecasts are included for telehome and telehospitals/clinics across different geographic markets.

Telemedicine Technologies Market

Published: March 2012
No. of Pages:168
Price: Single User License: US$ 4850              Corporate User License: US$ 8500 

Companies require clarity regarding the main markets for telemedicine technologies and services. BCC is interested in providing a comprehensive market forecast for multiple market segments (e.g., technologies, services, applications, geographical).

There has been a global focus on the use of telemedicine as a tool to cut down healthcare costs and bring about mammoth savings. Implementation of the new U.S. healthcare law will, if anything, intensify this focus, by increasing the number of people with health insurance and seeking medical services. In the near to mid-term, telemedicine technologies offer one of the few ways of enabling healthcare personnel to meet the increased demand without unacceptable delays or other forms of de facto rationing.

BCC is interested in studying the ways in which collaborative healthcare can be better and more economically implemented through telemedicine. Recently announced best practices to cut down global healthcare costs, including outsourced medical services, home-based treatment, intervention as opposed to post treatment, integrated information technology (IT) environments, increased efficiency of healthcare resources and reducing billing gaps, all point toward the increasing use of telemedicine.

BCC aims to identify the key success factors in the telemedicine market and to gauge the ways in which this market can significantly affect larger markets such as healthcare, health insurance, home care, telecommunications (telecom), networking, disease management, e-health and healthcare IT. The report is well timed, as major Tier I stakeholders are entering the telemedicine market.

The report provides telemedicine integrators with a market forecast of the telemedicine service market. It highlights value-added services and unique business models of telemedicine that can help to win business success.

Hospitals, home care companies, disease management companies, specialists and clinics can obtain a detailed market forecast for telecardiology, teleradiology, telepsychiatry, teledermatology, telepathology and other telemedicine applications.

Private and government health insurance companies will get a comprehensive and in-depth understanding of the global telemedicine market and all its main players. This report provides business cases to aid their decisions when investing in telemedicine.